Meritain Health policies
Search Meritain Health's public medical, payment and drug policies by CPT or HCPCS code, keyword or policy number, with links to the payer's own documents. Links open the payer's own document; check its current version before relying on it.
10 policies name J8560, those listing the fewest codes first. A policy that names a code may also list it as excluded.
| Policy | Details | Codes | Source |
|---|---|---|---|
| 0948-Emapalumab-lzsg (Gamifant) | 0948 · Commercial | 18 | Original policy ↗ |
| 0867-Clofarabine | 0867 · Commercial | 32 | Original policy ↗ |
| 0875-Bendamustine Products | 0875 · Commercial | 34 | Original policy ↗ |
| 0904-Daratumumab (Darzalex) and Daratumumab and Hyaluronidase-fihj (Darzalex Faspro) | 0904 · Commercial | 39 | Original policy ↗ |
| Atezolizumab (Tecentriq) and Atezolizumab and Hyaluronidase-tqjs (Tecentriq Hybreza) | 0909 · Commercial | 46 | Original policy ↗ |
| 0823-Brentuximab Vedotin (Adcetris) | 0823 · Commercial | 47 | Original policy ↗ |
| 0978-Lurbinectedin (Zepzelca) | 0978 · Commercial | 53 | Original policy ↗ |
| 0890-Pembrolizumab Products (Keytruda and Keytruda Qlex) | 0890 · Commercial | 82 | Original policy ↗ |
| Hematopoietic Colony-Stimulating Factors (CSFs) | 0055 · Commercial | 91 | Original policy ↗ |
| Antiemetic Therapy | 0724 · Commercial | 152 | Original policy ↗ |